ACCESSIBILITY

24/7

Headlines

21:44

"The next phase for Miami will be an increase in exits"

21:36

"There is nothing that Israeli high-tech cannot withstand"

15:16

"We see the biggest opportunities in residential construction"

15:05

"Our goal is to produce clean, affordable energy that supports the economy"

Buzz

Most popular

Daily

Weekly

Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"

Is your solitaire opponent actually a bot?

Once $5 billion IPO bound, Cybereason merges with Trustwave amid decline

Cloudera acquires Israeli startup Octopai to advance metadata and AI integration

Silverfort acquires Rezonate for several tens of millions to expand cloud security reach

More news

Pharma

20 stories about Pharma

Israeli Parliament Greenlights Cannabis Export, Pending Government Approval

26.12.18|Tzally Greenberg

The reform, meant to allow the export of medical cannabis farmed and processed in Israel, passed in the Israeli Parliament Tuesday

Lonza Opens Israeli Innovation Center

20.11.18|Lilach Baumer

The company announced plans for the center in 2017, stating it is looking to tap Israel's tech talent

Teva Investors Are Back on the Rollercoaster

27.09.18|Lilach Baumer

The stock of Teva Pharmaceutical Industries Ltd. fell over 11% on NYSE between September 20 and Thursday, bringing a halt to a nearly two weeks rally

Teva Shares Rise Following FDA Approval of Migraine Drug

16.09.18|Dror Reich

Teva’s new migraine drug is forecasted to bring in $500 million in sales annually

Gastro Treatment Company RedHill Jumps on Nasdaq Following Successful Clinical Trial

30.07.18|Lilach Baumer

The Tel Aviv-headquartered company stated its Crohn's disease treatment trial met its primary endpoint and key secondary endpoints

Gastro Treatment Company RedHill Wants to Raise $117 on Nasdaq

24.07.18|Lilach Baumer

The Tel Aviv-headquartered company announced on Monday that Nasdaq approved its listing on its second tier, the Global Market. RedHill's ADSs were previously listed on Nasdaq Capital Market

United Therapeutics to Acquire Pharma Company SteadyMed in a $216 Deal

30.04.18|Amarelle Wenkert

In 2017, Israeli-founded SteadyMed won a patent war against United Therapeutics

Pharma Company Opko Health Retracts Decision to Delist From the Tel Aviv Stock Exchange

29.04.18|Racheli Bindman

Dually listed on Nasdaq and TASE, Opko first submitted a request to delist from the TASE in early April

Israeli Cannabis Device Developer Kanabo to Set Up Marijuana Farm in Europe

27.04.18|Tofi Stoler

To carry out the plan, Kanabo is partnering with San Francisco-Based Cannabis Extract Manufacturer Constance Therapeutics

Israeli Pharmacies To Begin Selling Medical Marijuana Products

09.04.18|Sefi Krupsky

On April 20, selected Israeli pharmacies will begin selling prescription cannabis products as part of a pilot program for the regulation of medical marijuana sales in Israel

Teva Executive Calls Company’s Fourth Quarter “Fairly Good”

11.02.18|Dror Reich

Following the publication of the company's reports, S&P Global downgraded Teva’s corporate credit rating to junk bonds

Censa Pharmaceuticals Signs Joint Development Agreement with Biotech Company Retrophin

07.01.18|Lilach Baumer

Censa, a company developing treatments for orphan metabolic diseases, is a portfolio company of Israel-based Arkin Bio Ventures

Check Point Founder Invests in Clinical Stage Company Regenera Pharma

02.01.18|Dror Reich

The company intends to use the funding for a phase 3 clinical trial of its drug for sudden vision loss

מיקי שפירא וינשטוק זקלר ושות' Micki Shapira a partner at Weinstock Zecler _alt Co

The Year’s Seven Key Trends in Israeli Mergers and Acquisitions

29.12.17|Micki Shapira

Even without counting the Mobileye deal, 2017 was another strong year for M&A in Israel

Teva Wants to Be Like Mylan: Agile, Lean and Profitable

17.12.17|Uri Tal-Tenne

The cost-cutting plan revealed Thursday by Teva CEO Kåre Schultz showcases an intention to transform Teva into a lean and efficient generic drug company, much like main competitor Mylan

Employees Protest Outside Teva’s Israeli Facilities

14.12.17|Omer Kabir, Yoav Stoler and Keren-Or Grinberg

The demonstrations outside the company's facilities held Thursday foreshadow a full-out strike planned by the company’s employees for Sunday

Teva to Let Go 14,000 Employees Over the Next Two Years

14.12.17|Lilach Baumer

The company released a statement detailing its reconstruction plan Thursday. CEO Kåre Schultz elaborated on the plan during a call with investors

Israeli Pharma Company Wavelength Appoints New CEO

30.11.17|CTech

Pharma veteran Iftach Seri was named as Wavelength’s CEO. Formerly a Perrigo subsidiary, the company was recently sold to New York-based investment firm SK Capital for $110 million

Teva Announces Restructuring, Ousts Second in Command

27.11.17|Golan Hazani

The troubled Israeli drugmaker has combined its generic and specialty drug divisions, effective immediately

Generic Focus made Kite Pharma Founder Leave Teva

13.11.17|Dror Reich

Founder of cancer treatment company sold to Gilead Sciences for $12 billion, says Gilead wants “to crack the cancer market"

Previous Articles More Articles